A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma

Imagem de Miniatura
Arquivos
art_BATISTA_A_proposal_of_Brazilian_Society_of_Surgical_Oncology_2017.PDF (198.47 KB)
art_BATISTA_A_proposal_of_Brazilian_Society_of_Surgical_Oncology_2017_por.PDF (201.12 KB)
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2017
DOI
SciELO
Scopus
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
Colégio Brasileiro de Cirurgiões
Autores
BATISTA, Thales Paulo
SARMENTO, Bruno José Queiroz
LOUREIRO, Janina Ferreira
PETRUZZIELLO, Andrea
LOPES, Ademar
SANTOS, Cassio Cortez
QUADROS, Cláudio de Almeida
CORDEIRO, Eduardo Zanella
COIMBRA, Felipe José Fernández
Citação
REVISTA DO COLéGIO BRASILEIRO DE CIRURGIõES, v.44, n.5, p.530-544, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
ABSTRACT Cytoreductive surgery plus hypertermic intraperitoneal chemotherapy has emerged as a major comprehensive treatment of peritoneal malignancies and is currently the standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome as well as malignant peritoneal mesothelioma. Unfortunately, there are some worldwide variations of the cytoreductive surgery and hypertermic intraperitoneal chemotherapy techniques since no single technique has so far demonstrated its superiority over the others. Therefore, standardization of practices might enhance better comparisons between outcomes. In these settings, the Brazilian Society of Surgical Oncology considered it important to present a proposal for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil, with a special focus on producing homogeneous data for the developing Brazilian register for peritoneal surface malignancies.
RESUMO A cirurgia citorredutora com quimioterapia intraperitoneal hipertérmica emergiu como um importante tratamento das neoplasias peritoneais e é, atualmente, o padrão de atendimento para neoplasias epiteliais do apêndice associadas à síndrome de pseudomixoma peritoneal, bem como para o mesotelioma peritoneal maligno difuso. No mundo, existem algumas variações reconhecidas das técnicas de cirurgia citorredutora e quimioterapia intraperitoneal hipertérmica, entretanto nenhuma técnica até agora demonstrou sua superioridade sobre o outra. Portanto, a padronização destes procedimentos poderia melhorar a prática clínica e permitir a comparação adequada entre os resultados. Neste cenário, a Sociedade Brasileira de Cirurgia Oncológica considera importante a apresentação de uma proposta de padronização de procedimentos de cirurgia citorredutora com quimioterapia intraperitoneal hipertérmica no Brasil, com um foco especial na produção de dados homogêneos para o desenvolvimento do registro brasileiro das neoplasias peritoneais.
Palavras-chave
Injections, Intraperitoneal, Hyperthermia, Induced, Drug Therapy, Peritoneal Neoplasms, Injeções Intraperitoneais, Hipertermia Induzida, Quimioterapia, Neoplasias Peritoneais
URI
https://observatorio.fm.usp.br/handle/OPI/22259
Referências
  1. Akaishi E, 2009, WORLD J SURG, V33, P835, DOI 10.1007/s00268-008-9880-6
  2. Albuquerque TLC, 2015, Oncol, V41, pS199
  3. Alyami M, 2016, ANN SURG ONCOL, V23, pS737, DOI 10.1245/s10434-016-5519-2
  4. Arslan NC, 2017, SURG INFECT, V18, P157, DOI 10.1089/sur.2016.102
  5. Baiocchi G, 2016, ANN SURG ONCOL, V23, P1294, DOI 10.1245/s10434-015-4991-4
  6. Baratti D, 2013, EUR J CANCER, V49, P3140, DOI 10.1016/j.ejca.2013.05.027
  7. Baratti D, 2012, ANN SURG ONCOL, V19, P1416, DOI 10.1245/s10434-012-2237-2
  8. Baratti D, 2010, WORLD J GASTRO ONCOL, V2, P36, DOI 10.4251/wjgo.v2.i1.36
  9. BATISTA THALES PAULO, 2016, Rev. Col. Bras. Cir., V43, P476, DOI 10.1590/0100-69912016006014
  10. Brito FPB, 2015, Oncol, V41, pS201
  11. Caneparo A, 2014, EJSO-EUR J SURG ONC, V40, P925, DOI 10.1016/j.ejso.2014.03.013
  12. Carr NJ, 2016, AM J SURG PATHOL, V40, P14, DOI 10.1097/PAS.0000000000000535
  13. Campos PAC, 2011, EJSO-EUR J SURG ONC, V37, P543, DOI 10.1016/j.ejso.2011.03.134
  14. Cascales-Campos PA, 2016, SURG ONCOL, V25, P349, DOI 10.1016/j.suronc.2016.08.001
  15. Cereser Junior CH, 2015, Oncol, V41, pS202
  16. Charrier T, 2016, ANN SURG ONCOL, V23, P2315, DOI 10.1245/s10434-016-5143-1
  17. Chua TC, 2012, J CLIN ONCOL, V30, P2449, DOI 10.1200/JCO.2011.39.7166
  18. Colantonio L, 2015, J GASTROINTEST SURG, V19, P722, DOI 10.1007/s11605-015-2743-1
  19. Cordeiro EZ, 2015, Oncol, V41, pS200
  20. Costa WL, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-195
  21. Cotte E, 2010, WORLD J GASTRO ONCOL, V2, P31, DOI 10.4251/wjgo.v2.i1.31
  22. Cummins KA, 2016, J GASTROINTEST ONCOL, V7, P3, DOI 10.3978/j.issn.2078-6891.2015.101
  23. Dagbert F, 2016, ANN SURG ONCOL, V23, P1980, DOI 10.1245/s10434-016-5147-x
  24. Davies JM, 2002, CLIN MED, V2, P440
  25. de Cuba EMV, 2014, ANN SURG ONCOL, V21, P883, DOI 10.1245/s10434-013-3370-2
  26. Deraco M, 2013, ANN SURG ONCOL, V20, P1093, DOI 10.1245/s10434-012-2845-x
  27. Deraco M, 2009, J SURG ONCOL, V100, P321, DOI 10.1002/jso.21388
  28. Esquivel J, 2008, J SURG ONCOL, V98, P263, DOI 10.1002/jso.21053
  29. Facy O, 2015, SURGERY, V157, P72, DOI 10.1016/j.surg.2014.06.006
  30. Firmino NLJ, 2015, Oncol, V41, pS199
  31. Foster JM, 2012, AM SURGEON, V78, P171
  32. Gaspar Gilberto Gambero, 2015, Rev. Soc. Bras. Med. Trop., V48, P77, DOI 10.1590/0037-8682-0292-2014
  33. Glehen O, 2003, ANN SURG ONCOL, V10, P863, DOI 10.1245/ASO.2003.01.018
  34. Glehen O, 2008, J SURG ONCOL, V98, P242, DOI 10.1002/jso.21061
  35. Glockzin G, 2013, J SURG ONCOL, V107, P574, DOI 10.1002/jso.23228
  36. Gonzalez-Moreno S, 2008, J SURG ONCOL, V98, P237, DOI 10.1002/jso.21072
  37. Gonzalez-Moreno S, 2010, WORLD J GASTRO ONCOL, V2, P68, DOI 10.4251/wjgo.v2.i2.68
  38. Halkia E, 2015, Int J Surg Oncol, V2015, P610597, DOI 10.1155/2015/610597
  39. Helm JH, 2015, ANN SURG ONCOL, V22, P1686, DOI 10.1245/s10434-014-3978-x
  40. Hettinga JVE, 1997, INT J HYPERTHER, V13, P439, DOI 10.3109/02656739709023545
  41. Hjerpe A, 2015, CYTOJOURNAL, V12, DOI 10.4103/1742-6413.170726
  42. Husain AN, 2013, ARCH PATHOL LAB MED, V137, P647, DOI 10.5858/arpa.2012-0214-OA
  43. Ihemelandu C, 2016, ANN SURG ONCOL, V23, P1474, DOI 10.1245/s10434-015-4995-0
  44. Kepenekian V, 2016, EUR J CANCER, V65, P69, DOI 10.1016/j.ejca.2016.06.002
  45. Kindler Hedy Lee, 2013, Am Soc Clin Oncol Educ Book, P182, DOI 10.1200/EdBook_AM.2013.33.182
  46. Konate A, 2011, J SURG ONCOL, V103, P6, DOI 10.1002/jso.21740
  47. Kusamura S, 2008, J SURG ONCOL, V98, P247, DOI 10.1002/jso.21051
  48. Kusamura S, 2008, J SURG ONCOL, V98, P232, DOI 10.1002/jso.21058
  49. Kusamura S, 2016, ANN SURG ONCOL, V23, P1468, DOI 10.1245/s10434-015-4962-9
  50. Lam JY, 2015, AM J SURG, V210, P424, DOI 10.1016/j.amjsurg.2015.03.008
  51. Lambert LA, 2015, CA-CANCER J CLIN, V65, P283, DOI 10.3322/caac.21277
  52. Lehmann K, 2016, WORLD J SURG, V40, P1075, DOI 10.1007/s00268-015-3366-0
  53. Leung V, 2017, EJSO-EUR J SURG ONC, V43, P144, DOI 10.1016/j.ejso.2016.09.015
  54. Levine EA, 2014, J AM COLL SURGEONS, V218, P573, DOI 10.1016/j.jamcollsurg.2013.12.013
  55. Lopez-Basave Horacio N, 2014, J Oncol, V2014, P307317, DOI 10.1155/2014/307317
  56. Lopez-Lopez V, 2016, SURG ONCOL, V25, P378, DOI 10.1016/j.suronc.2016.09.002
  57. Maciver AH, 2017, ANN SURG ONCOL, V24, P923, DOI 10.1245/s10434-016-5692-3
  58. Mavroudis C, 2015, INT SURG, V100, P1033, DOI 10.9738/INTSURG-D-14-00138.1
  59. McConnell YJ, 2013, J SURG ONCOL, V107, P591, DOI 10.1002/jso.23276
  60. Mehta AM, 2015, INT J PHARMACEUT, V479, P23, DOI 10.1016/j.ijpharm.2014.12.025
  61. Mehta AM, 2017, ANN SURG ONCOL, V24, P990, DOI 10.1245/s10434-016-5665-6
  62. Milovanov V, 2016, ANN SURG ONCOL, V23, P1928, DOI 10.1245/s10434-015-5047-5
  63. Moulis G, 2015, AM J HEMATOL, V90, P301, DOI 10.1002/ajh.23930
  64. Oliveira DNA, 2015, Oncol, V41, pS200
  65. Passot G, 2016, J SURG ONCOL, V113, P796, DOI 10.1002/jso.24248
  66. Pelz JOW, 2013, ANN SURG ONCOL, V20, P1105, DOI 10.1245/s10434-012-2784-6
  67. Pillai K, 2015, AM J CLIN ONCOL-CANC, V38, P388, DOI 10.1097/COC.0b013e3182a0e867
  68. Portilla AG, 2008, J SURG ONCOL, V98, P228, DOI 10.1002/jso.21068
  69. Prada-Villaverde A, 2014, J SURG ONCOL, V110, P779, DOI 10.1002/jso.23728
  70. Quenet F, 2011, ANN SURG, V254, P294, DOI 10.1097/SLA.0b013e3182263933
  71. Raspe C, 2017, EJSO-EUR J SURG ONC, V43, P1013, DOI 10.1016/j.ejso.2016.09.008
  72. Reis TJCC, 2015, Oncol, V41, pS201
  73. Reis TJCC, 2015, Oncol, V41, pS202
  74. Reis TJCC, 2015, Oncol, V41, pS200
  75. Rettenmaier MA, 2015, INT J HYPERTHER, V31, P396, DOI 10.3109/02656736.2015.1007399
  76. Riss S, 2015, EJSO-EUR J SURG ONC, V41, P392, DOI 10.1016/j.ejso.2014.09.002
  77. Rodriguez Silva Cristina, 2017, World J Surg Oncol, V15, P51, DOI 10.1186/s12957-017-1119-2
  78. Schaaf L, 2015, ANN SURG ONCOL, V22, pS758, DOI 10.1245/s10434-015-4853-0
  79. Shetty SJ, 2014, AM SURGEON, V80, P348
  80. SPRATT JS, 1980, CANCER RES, V40, P256
  81. Sugarbaker PH, 2007, INT J HYPERTHER, V23, P431, DOI 10.1080/02656730701455318
  82. Sugarbaker PH, 2017, ANN SURG ONCOL, V24, P729, DOI 10.1245/s10434-016-5632-2
  83. Sugarbaker PH, 2016, ANN SURG ONCOL, V23, P1481, DOI 10.1245/s10434-015-4961-x
  84. Sugarbaker PH, 2006, LANCET ONCOL, V7, P69, DOI 10.1016/S1470-2045(05)70539-8
  85. SUGARBAKER PH, 1995, ANN SURG, V221, P29, DOI 10.1097/00000658-199501000-00004
  86. Sugarbaker PH, 2013, TRANSL GASTROINTEST, V2, P54
  87. Taflampas P, 2014, EJSO-EUR J SURG ONC, V40, P515, DOI 10.1016/j.ejso.2013.12.021
  88. Takahashi RM, 2015, Oncol, V41, pS203
  89. Turner KM, 2013, ANN SURG ONCOL, V20, P1068, DOI 10.1245/s10434-012-2789-1
  90. Valle M, 2014, EJSO-EUR J SURG ONC, V40, P950, DOI 10.1016/j.ejso.2013.10.015
  91. Velasquez ARE, 2015, Oncol, V41, pS201
  92. Verwaal VJ, 2008, J SURG ONCOL, V98, P220, DOI 10.1002/jso.21060
  93. Vieira HC, 2015, Oncol, V41, pS199
  94. Villa AF, 2015, IND HEALTH, V53, P28, DOI 10.2486/indhealth.2014-0025
  95. Witkamp AJ, 2001, CANCER TREAT REV, V27, P365, DOI 10.1054/ctrv.2001.0232
  96. Yan TD, 2008, J SURG ONCOL, V98, P224, DOI 10.1002/jso.21069
  97. Yan TD, 2011, CANCER-AM CANCER SOC, V117, P1855, DOI 10.1002/cncr.25640
  98. Yan TD, 2009, J CLIN ONCOL, V27, P6237, DOI 10.1200/JCO.2009.23.9640
  99. Younan R, 2008, J SURG ONCOL, V98, P253, DOI 10.1002/jso.21057
  100. Zunino B, 2016, ONCOGENE, V35, P261, DOI 10.1038/onc.2015.82

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - LIM/62
Artigos e Materiais de Revistas Científicas - ODS/03